New York, NY (PRWEB) July 17, 2011
Parker Waichman Alonso LLP, a national law firm that represents victims of defective medical devices, is now evaluating claims on behalf of women who may have been injured as a result of transvaginal mesh devices marketed by American Medical Systems and other manufacturers. For more information about transvaginal mesh side effects, please visit our transvaginal mesh injury page http://www.yourlawyer.com/topics/overview/transvaginal_mesh_injuries at http://www.yourlawyer.com. The page will be updated regularly as more information becomes available.
Transvaginal mesh devices, including those manufactured by American Medical Systems, are implanted in women during surgical procedures to repair pelvic organ prolapse (POP) and stress urinary incontinence (SUI). In a Safety Communication issued on July 13, 2011, the U.S. Food & Drug Administration (FDA) warned that use of transvaginal mesh during surgery to treat POP may carry more risks than other surgical options. At the same time, the agency noted that there was very little evidence that POP repair with transvaginal mesh offered patients any additional benefits compared to other surgical options.
The new FDA alert was an update to a Safety Communication the agency issued in October 2008, when it reported 1,000 complications associated with transvaginal mesh. In its July 2011 Safety Communication, the FDA said that since that time, it has received an additional 2,874 reports of complications associated with the use of transvaginal mesh. Of those, just over 1,500 were related to the use of transvaginal mesh in POP repair, representing a five-fold increase since its previous alert. The most common side effects reported to the FDA included erosion through the vaginal tissue, pain, infection, bleeding, pain during intercourse, organ perforation during placement, and urinary problems. The FDA emphasized that POP transvaginal mesh complications are not rare, a change from the position it took in 2008.
In addition to American Medical Systems, transvaginal mesh is manufactured and marketed by a number of companies, including C.R. Bard and Mentor Corp., a division of Johnson & Johnson. Lawsuits involving Mentor's ObTape Transobturator Sling products are consolidated in a multidistrict litigation in the U.S. District Court for the Southern District of Georgia (MDL No. 2004 - In Re: Mentor Corp. ObTape Transobturator Sling Products Liability Litigation). Last October, litigation involving C.R. Bard’s Avaulta mesh products was consolidated as part of a multidistrict litigation in the U.S. District Court for the Southern District of West Virginia (MDL No. 2187 - In Re Avaulta Pelvic Support Systems Products Liability Litigation).
Parker Waichman Alonso LLP urges anyone who has undergone transvaginal mesh POP surgery to seek immediate medical help if they experience symptoms of complications, and then contact a personal injury lawyer with experience in medical device litigation.
About Parker Waichman Alonso LLP
Parker Waichman Alonso LLP is a leading personal injury law firm that represents plaintiffs nationwide. The firm has offices in New York, New Jersey, Florida and Washington, D.C. Parker Waichman Alonso LLP has assisted thousands of clients in receiving fair compensation for injuries resulting from defective medical devices, drugs side effects and other products.
For more information on Parker Waichman Alonso LLP, please visit: http://www.yourlawyer.com or call 1-800-LAW-INFO (1-800-529-4636).
Parker Waichman Alonso LLP
David B. Krangle, Esq.